3D超声心动图在导线介导三尖瓣反流中的应用价值

张文成; 鲁星琴; 陈凤梅; 莫乔莹; 姚亚丽

doi:10.13201/j.issn.1001-1439.2020.01.004

3D超声心动图在导线介导三尖瓣反流中的应用价值

- 兰州大学第一医院心血管内科(兰州, 730000)
基金项目:
甘肃省卫生行业科研计划项目(No:GSWSKY-2015-45)

详细信息

通讯作者: 姚亚丽,E-mail:yaoyalifs@163.com

中图分类号: R541.3

收稿日期: 2019-07-15

Application value of 3D echocardiography in lead-induced tricuspid regurgitation

- Department of Cardiology, The First Hospital of Lanzhou University, Lanzhou, 730000, China

More Information

Corresponding author: YAO Yali, E-mail: yaoyalifs@163.com

Received Date: 15 July 2019

摘要

摘要: 长期以来,导线介导的三尖瓣反流(lead-induced tricuspid regurgitation,LITR)作为起搏器医源性并发症并未得到充分认识与重视。常规超声在LITR成像诊断存在缺陷。近年来随着三维超声心动图(Three-dimensional echocardiography,3DE)的使用,在心脏介入手术管理中发挥着越来越重要的作用,可用于LITR的病理机制研究及反流严重程度的评估。
- 导线介导三尖瓣反流 /
- 二维超声心动图 /
- 三维超声心动图
Abstract: lead-induced tricuspid regurgitation(LITR) as a pacemaker iatrogenic complication has not been fully recognized and attached neither clinically or echocardiographically for a long time.Conventional two-dimensional has some inherent limitations in identifying tricuspid valve morphology and diagnosing the LITR.Recently,Three-dimensional echocardiography(3DE) presents an increasingly important role in the management of interventional cardiac procedures.It can be used to assessing the pathological mechanism of LITR and the assessment of the severity of tricuspid regurgitation.
- lead-induced tricuspid regurgitation /
- two-dimensional echocardiography /
- three-dimensional echocardiography

HTML全文

参考文献(30)

[1]	Addetia K,Harb SC,Hahn RT,et al.Cardiac implantable electronic device lead-induced tricuspid regurgitation[J].JACC:Cardiovasc Imaging,2019,12(4):622-636.
[2]	Chang JD,Manning WJ,Ebrille E,et al.Tricuspid valve dysfunction following pacemaker or cardioverter-defibrillator implantation[J].J Am Coll Cardiol,2017,69(18):2331-2341.
[3]	Ancardeen K,Rao R,Hazra S,et al.Prevalence and significance of tricuspid regurgitation post-endocardial lead placement[J].JACC:Cardiovas Imaging,2019,12(3):562-564.
[4]	Fanari Z,Hassan ZK,Hammami MB,et al.The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation[J].J Electrocardiol,2015,48(5):791-797.
[5]	Delling FN,Hassan ZK,Piatkowski G,et al.Tricuspid regurgitation and mortality in patients with transvenous permanent pacemaker leads[J].Am J Cardiol,2016,117(6):988-992.
[6]	Hoke U,Auger,D,Thijssen,J,et al.Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up[J].Heart,2014,100(12):960-968.
[7]	Al-Bawardy R,Krishnaswamy A,Rajeswaran J,et al.Tricuspid regurgitation and implantable devices[J].Pacing Clin Electrophysiol,2015,38(2):259-266.
[8]	Addetia K,Maffessanti F,Mediratta A,et al.Impact of implantable transvenous device lead location on severity of tricuspid regurgitation[J].J Am Soc Echocardiogr,2014,27(11):1164-1175.
[9]	Taramasso M,Gavazzoni M,Pozzoli A,et al.Tricuspid regutgitation:predicting the need for intervention,Procedural success,and recurrence of disease [J].JACC:Cardiovasc Imaging,2019,12(4):605-621.
[10]	Nath J,Foster E,Heidenreich PA.Impact of tricuspid regurgitation on long-term survival[J].J Am Coll Cardiol,2004,43(3):405-409.
[11]	Delling FN,Hassan,Zena K,Piatkowski,Gail,et al.Tricuspid Regurgitation and Mortality in Patients with Transvenous Permanent Pacemaker Leads[J].Am J Cardiol,2016,117(6):988-992.
[12]	Lee RC,Friedman SE,Kono AT,et al.Tricuspid regurgitation following implantation of endocardial leads:incidence and predictors[J].Pacing and Clinical Electrophysiology,2015,38(11):1267-1274.
[13]	Dokainish H,Elbarasi E,Masiero S,et al.Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation:Background,rationale,and design[J].Global Cardiology Science and Practice,2015,2015(3):41.
[14]	Trankle CR,Gertz ZM,Koneru JN,et al.Severe tricuspid regurgitation due to interactions with right ventricular permanent pacemaker or defibrillator leads[J].Pacing Clin Electrophysiol,2018,41(7):845-853
[15]	Pfannmueller B,Hirnle G,Seeburger J,et al.Tricuspid valve repair in the presence of a permanent ventricular pacemaker lead[J].Eur J Cardiothoracic Surg,2011,39(5):657-661.
[16]	Saito M,Iannaccone A,Kaye G,et al.Effect of right ventricular pacing on right ventricular mechanics and tricuspid regurgitation in patients with high-grade atrioventricular block and sinus rhythm (from the Protection of Left Ventricular Function During Right Ventricular Pacing Study)[J].Am J Cardiol,2015,116(12):1875-1882.
[17]	Vaturi M,Kusniec J,Shapira Y,et al.Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode[J].Eur J Echocardiogr,2010,11(6):550-553.
[18]	Lin G,Nishimura RA,Connolly HM,et al.Severe Symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads[J].J Am Coll Cardiol,2005,45(10):1672-1675.
[19]	Fadel BM,Almulla K,Husain A,et al.Spectral doppler of the hepatic veins in tricuspid valve disease[J].Echocardiography,2015,32(5):856-859.
[20]	Mediratta A,Addetia K,Yamat M,et al.3D Echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation[J].JACC:Cardiovascular Imaging,2014,7(4):337-347.
[21]	Miglioranza MH,Becker D,Jiménez-Nácher JJ,et al.A new view of an unusual pacemaker complication:role of three-dimensional transthoracic echocardiography[J].Echocardiography,2013,30(6):E164-E166.
[22]	Cheng Y,Gao H,Tang L,et al.Clinical utility of three-dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads[J].Echocardiography,2016,33(11):1689-1696.
[23]	Seo Y,Ishizu T,Nakajima H,et al.Clinical utility of 3-Dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads[J].Circ J,2008,72(9):1465-1470.
[24]	Ren JF,Callans DJ,Marchlinski FE.Tricuspid regurgitation severity associated with positioning of RV lead or other etiology assessed by intracardiac echocardiography[J].JACC Cardiovascular Imaging,2014,7(12):1285-1286.
[25]	Chen TE,Kwon SH,Enriquez-Sarano M,et al.Three-Dimensional color doppler echocardiographic quantification of tricuspid regurgitation orifice area:comparison with conventional two-Dimensional measures[J].J Am Soc Echocardiogr,2013,26(10):1143-1152.
[26]	Tribouilloy CM,Enriquez-Sarano M,Bailey KR,et al.Quantification of tricuspid regurgitation by measuring the width of the vena contracta with Doppler color flow imaging:a clinical study[J].J Am Coll Cardiol,2000,36(2):472-478.
[27]	Bongiorni MG,Burri H,Deharo JC,et al.2018 EHRA expert consensus statement on lead extraction:recommendations on definitions,endpoints,research trial design,and data collection requirements for clinical scientific studies and registries:endorsed by APHRS/HRS/LAHRS[J].Europace,2018,20(7):1217.
[28]	Chang JD,Manning WJ,Ebrille E,et al.Tricuspid valve dysfunction following pacemaker or cardioverter-defibrillator implantation[J].J Am Coll Cardiol,2017,69(18):2331-2341.
[29]	杨力凡,周达新.三尖瓣反流的介入治疗进展[J].临床心血管病杂志,2018,34(4):327-329.
[30]	Taramasso M,Gavazzoni M,Pozzoli A,et al.Tricuspid regurgitation:predicting the need for interventiong,procedural success,and recurrence of disease[J].JACC:Cardiovascular Imaging,2019,12(4):605-621.